Citigroup »

Tvardi Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $897 276 3.25

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
Vanguard Capital Management
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Silvercrest Asset Management Group
Morgan Stanley
Duncan Williams Asset Management
UBS Group
Northern Trust
Vanguard Fiduciary Trust
Farallon Capital Management

View all funds holding Tvardi Therapeutics